BackTheratechnologies Overview

Theratechnologies Receivables

Latest receivables for THTX: $11M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$11.37M
16.16% YoYΔ $-2.19M vs prior year quarter

Peer trimmed avg / median

Loading

Theratechnologies Receivables History

Loading

Theratechnologies vs. peers: Receivables Comparison

Loading

Theratechnologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Theratechnologies (THTX) FAQ

As of the most recent data (May 2025), THTX shows a receivables of $11M. That compares with $14M in the prior-year period — down 16.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, THTX's receivables is now $11M (was $14M) — a 16.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Theratechnologies is outperforming or lagging.

Tracking THTX's receivables over time shows whether Theratechnologies is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $14M in the prior-year period — down 16.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Theratechnologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $11M) with ownership activity and broader fundamentals.

Theratechnologies's receivables is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.